Werthessen and his collaborators (2-4) reported that incubation of estrone in blood produced the destruction of the 17-ketone function of the steroid, accompanied by a loss of biological activity. On the other hand, Bischoff and associates (5, 6) incubated the red blood cells of rabbit or man with estrone and observed a marked increase of the biological activity of the added steroid. The discrepancy in the two sets of data was ascribed at the time to differences either in assay techniques or in experimental conditions. A similar increase in biological activity was reported by Repke and Markwardt (7), who used red cells of the guinea pig, rabbit, and man. It now appears that species differences were the cause of this discrepancy. In most of these experiments, Werthessen and co-workers (3, 4) used bovine blood, and Axelrod and Werthessen (8) have found that in this species estrone is converted to the extent of 88 per cent into estradiol-17a. The investigations of Bischoff and associates (5, 6) were carried out with rabbit and human red cells, and these authors (9) have shown that the main reaction product resulting from estrone incubation in their system was estradiol; the latter report, however, failed to mention whether the steroid detected was the a-or 8-isomer, but there are reasons to believe that reaction product was estradiol-17/3. This isomer is biologically more active than estrone or estradiol-17a; hence the difference in the results reported by Werthessen and co-workers (3, 4) and Bischoff and associates (5, 6) . In a study of the stereospecificity of the activity of estradiol dehydrogenases in the erythrocytes of man and of various animals, Portius and Repke (10) showed that an estradiol-17,8 dehydrogenase was present in the red cells of the 15 species investigated, whereas an estradiol-17a dehydrogenase was found only in ruminants such as cow, sheep, and goat. The same authors (10) reported that the activity of the fl-enzyme was the highest in the rat and the lowest in man.
Werthessen and his collaborators (2) (3) (4) reported that incubation of estrone in blood produced the destruction of the 17-ketone function of the steroid, accompanied by a loss of biological activity. On the other hand, Bischoff and associates (5, 6) incubated the red blood cells of rabbit or man with estrone and observed a marked increase of the biological activity of the added steroid. The discrepancy in the two sets of data was ascribed at the time to differences either in assay techniques or in experimental conditions. A similar increase in biological activity was reported by Repke and Markwardt (7) , who used red cells of the guinea pig, rabbit, and man. It now appears that species differences were the cause of this discrepancy. In most of these experiments, Werthessen and co-workers (3, 4) used bovine blood, and Axelrod and Werthessen (8) have found that in this species estrone is converted to the extent of 88 per cent into estradiol-17a. The investigations of Bischoff and associates (5, 6) were carried out with rabbit and human red cells, and these authors (9) have shown that the main reaction product resulting from estrone incubation in their system was estradiol; the latter report, however, failed to mention whether the steroid detected was the a-or 8-isomer, but there are reasons to believe that reaction product was estradiol-17/3. This isomer is biologically more active than estrone or estradiol-17a; hence the difference in the results reported by Werthessen and co-workers (3, 4) and Bischoff and associates (5, 6) . In a * This work was made possible by grants-in-aid A-180 (CIO), H-3995, and B-1612 from the National Institute of Health, U. S. Public Health Service. The data were presented at the First International Congress of Endocrinology, Copenhagen, 1960 (1) . study of the stereospecificity of the activity of estradiol dehydrogenases in the erythrocytes of man and of various animals, Portius and Repke (10) showed that an estradiol-17,8 dehydrogenase was present in the red cells of the 15 species investigated, whereas an estradiol-17a dehydrogenase was found only in ruminants such as cow, sheep, and goat. The same authors (10) reported that the activity of the fl-enzyme was the highest in the rat and the lowest in man.
Bischoff and associates (6) have investigated some of the conditions influencing the "activation" of estrone, but the degree of transformation of the steroid was determined by bio-assay. Repke and Markwardt (7) have also studied this problem using the Allen-Doisy test as an index of "activation" of estrone, and have found that neither the succinic dehydrogenase systems nor the enzyme systems involved in red cell glycolysis were able to transform estrone to estradiol-17,8. In another paper, the same workers (11 ) reported that preparations of glucose-6-phosphate dehydrogenase of either guinea pig red cells or yeast (12) 16 -C'4-estradiol-17p, the glucose solution was replaced by 0.1 ml of 0.9 per cent NaCl solution.
The mixture was incubated at 370C for 24 hours. On several occasions, the incubation mixtures were checked for the presence of microorganisms, but the cultures were negative. At the end of the incubation, the steroids were extracted twice with 4 ml of ethanol and once with 4 ml of a 1: 1 (vol/vol) mixture of ethanol and butanol. The pooled extracts were then evaporated to dryness and the residue was mixed with 3 ml of distilled water. The aqueous phase was extracted five times with 6 ml of chloroform, and the combined chloroform was evaporated to dryness. The residue was applied on Whatman paper No. 2 and chromatographed as previously described (16) . The paper chromatogram was radioautographed (16) , the area corresponding to estrone and estradiol-17j, was eluted with ethanol, and the amount of radioactivity present in the eluates was determined.
When variations were made in the basic system, the final volume of 1.3 ml was maintained by an appropriate change in the volume of saline solution added. The only exception was in the experiments on the effect of the amount of red cells used (with 2 and 3 ml of red cells, the final volumes were 2.3 and 3.3 ml, respectively). In the experiments on the effect of pH, 0.5 ml of buffer solution replaced the 0.5 ml of saline solution. In other experiments, the saline solution was replaced by 0.5 ml of 1, 0.5, 0.25, and 0.12 per cent citric acid in saline solution in order to bring the initial pH of the mixture to 5.2, 5.8, i 6.3, and 6.6, respectively; 0.5 ml of 0.75, 0.5, and 0.25 per s cent Na2CO3 in saline solution was used for obtaining an i initial pH of 9.2, 8.7, and 7.9. In the inhibition experi-c ments, methylene blue and sodium fluoride were dis-X solved in saline solution, and 0.5 ml of these mixtures replaced the regular saline solution.
Basic experimental system in experiments with hemolyzed erythrocytes. A volume of 0.5 ml of washed red cells was transferred by pipet into a test tube which was placed in a freezer at -50'C for 30 minutes. After thawing, various solutions were added as indicated in each corresponding Table. Finally, the estrogen solution was added and the final volume was brought to 2.1 ml with 0.9 per cent NaCl solution. The samples were then treated as described for the intact red cells.
In experiments in which red cell ghosts were removed, this procedure was followed: After the freezing of a known volume of red cells, saline solution was added (1.5 the volume of red cells) ; the mixture was centrifuged at 28,000 X G, at 50C for 60 minutes; 1.25 ml of the aqueous solution was used for these experiments.
For the (NH4)2SO4 precipitation, the red cell ghosts were removed, and to 4 ml of the red cell hemolysate an equal volume of either 50 per cent, 75 per cent, or 100 per cent (NH4)2SO was added, giving a final concentration of 25, 37.5, and 50 per cent, respectively. The mixture was centrifuged at 28,000 X G at 50C for 60 minutes. Two ml of supernatant fluid (corresponding to 0.5 ml of initial red cells), 0.3 ml of 0.01 M TPN, and 0.3 ml of 16-C14-estradiol-17,8 were incubated and then treated as described above. Each of the precipitates was dissolved in 2 ml of saline; 0.5 ml of this solution, 0.3 ml of 0.01 M TPN, 0.3 ml of 16-C14-estradiol-17j,6 and 1.5 ml of saline were also incubated.
The DEAE (diethylaminoethyl cellulose) used for column fractionation was washed with IN NaOH, 0.9 per cent NaCl solution, 95 per cent ethanol, and then was dried. Prior to use, 0.9 per cent NaCl solution was added to DEAE and the pH adjusted to 7.0. A column of 1.8 cm in diameter and 8.0 cm in length was prepared. Prior to applying the red cell hemolysate, the column was washed with 50 ml of cold 0.005 M NaCl. Elution of the column was then carried out by adding increasing concentrations of NaCl solution and by collecting 10 ml -fractions. A 4-ml sample of each of these fractions, 0.3 ml of 0.01 M TPN, and 0.3 ml of 16-C14-estradiol-17fi were incubated and then treated as described above.
Recovery. The radioactivity recovered after extraction of the basic experimental system and prior to paper chromatography represented 94 to 103 per cent of the radioactivity originally added to the system. In all the experiments, the sum of the activities eluted from the areas of the paper chromatograms corresponding to estrone and estradiol-17,8 represented 85 to 92 per cent of the radioactivity added at the beginning of the experiment.
When the extract of more than 0.5 ml of red cells was chromatographed, the increased amount of nonsteroidal impurities was found to produce a displacement of the steroids on the paper chromatogram. For Brown (19) , and the specific activity of the methylated compound on two successive crystallizations is shown in Table I . A sample of the pooled mother solutions of the two preceding crystallizations was chromatographed as described by Brown (19) , and the amount of Kober chromogen and of radioactivity was determined in the estradiol fraction. From the amount of estradiol present as determined by the Kober reaction, the specific activity was calculated to be 3,080 cpm per mg.
By similar criteria, the product resulting from the incubation of 16-C14-estradiol-17,8 with red blood cells was found to be radioactive estrone (see Table I ). Some of the radioautograms showed that a certain amount of radioactivity (about 4.8 per cent of the total activity) remained on the starting line of the papergram. It is thought to be due to nonspecific adsorption of the radiocompounds on the area of the paper where the extract was applied. On occasion a small quantity of radioactivity was detected also at the solvent front of the paper; such radioactivity, however, was closely related to nonpolar impurities of the extracts that were detectable by their fluorescence in ultraviolet light and by their absorption of this light when a fluorescence scanner was used (20) (Table II) .
When estradiol-17,8 was used as substrate, its transformation was inhibited by glucose ( Figure   1 ). 6 . Effect of duration of incubation at 37°C. A 24-hour incubation was found to produce the maximum transformation (Figure 2 ). Shorter periods of incubation resulted in smaller percentages of transformation.
7. Effect of temperature of incubation. As shown in Figure 3, .: .:
. 12. Subjects with a deficiency of the red cell glucose-6-phosphate dehydrogenase and their relatives. The results are shown in Table IV . In the patients with congenital nonspherocytic hemolytic anemia, the percentage of transformation of estrone to estradiol-17,8 was markedly reduced. It was normal in the fathers of the patients and the wife of one, but it was at the lower limit of the normal range in the two tested mothers of patients. Table  IV shows that these two mothers had a somewhat decreased glucose-6-phosphate dehydrogenase activity in their red cells and are usually referred to * The results are the mean values of a number of experiments as indicated in parentheses. Abbreviations: G-6-P = glucose-6-phosphate; El = estrone; E2 = estradiol-17,9.
as "female intermediates" (23). It is not possible at the present time to tell whether the slight decrease in transformation of estrone in these two mothers was due to the relative decrease in enzyme activity of their red cells.
The six Negroes and the Jewish subject with primaquine-sensitive erythrocytes also had a reduced transformation of estrone to estradiol-17,8.
On the other hand, the conversion of estradiol-17,3 to estrone by the red cells of the subjects studied was found to be in the range of the values obtained for normal males and females (Figure 7) . RESULTS In subjects with a deficiency of glucose-6-phosphate dehydrogenase, the transformation of glucose-6-phosphate to 6-phospho-gluconolactone was very limited, resulting in decreased formation of TPNH. Since the transformation of estrone to estradiol-17,8e was greatly limited in these subjects, this indicates that TPNH is the hydrogen donor for the reaction catalysed by estradiol-17,8 dehydrogenase. On the other hand, the transformation of estradiol-17,8 to estrone that required a hydrogen acceptor was normal in these subjects. The fact that in subjects with red cell glucose-6-phosphate dehydrogenase deficiency some estrone was transformed probably means that the deficiency was not complete. At the same time, if glucose-6-phosphate dehydrogenase is not completely absent, one would expect that enough TPNH would be generated to reduce the minute amounts of estrone that are being offered as substrate in the present experiments unless more active and more abundant TPNH-oxidizing systems are also present in the red cells. Such a possibility is to be considered, although it remains to be proved. The two dehydrogenases of the hexose monophosphate shunt are TPN-specific. The two dehydrogenases present in the Embden-Meyerhof-Parnas glycolytic pathway are DPN-dependent. In addition to the glucose-6-phosphate dehydrogenase system, one of the three other hydrogen transfers of the glycolysis could be coupled with the hydrogen transfer by the estradiol-17/3 dehydrogenase. The addition of DPN to hemolyzed red cells did not produce any significant transformation of estradiol-17,8. Therefore, only the 6-phospho-gluconic dehydrogenase could possibly be coupled to the estradiol-17,/ dehydrogenase system; this, however, has not been determined.
The occurrence of pyridine nucleotide transhydrogenase activity in animal tissue mitochondria has been reported (25) . An enzyme system which is specifically stimulated by estrogens added in vitro has been demonstrated in human placental preparations (26) , and it was found that this system catalyzed a pyridine nucleotide transhydrogenation (27, 28) . More recently, an estradiol-17,/ dehydrogenase has been separated from the estrogen-sensitive transhydrogenase (29) . Whether the human red cell enzyme is identical with the estradiol-17/8 dehydrogenase found in human placenta has not been determined. Since it is impossible to remove all the blood contained in placental tissue, placental estradiol-17,B dehydrogenase activity could be partially of red cell origin. The behavior of the placental system described by Ryan and Engel (30) , however, would seem to argue against erythrocyte origin for the placental dehydrogenase.
The role and the importance of the estradiol-17,8-dehydrogenase in human red cells is not known. The fact that this enzyme system is in large part coupled with the glucose-6-phosphate dehydrogenase might suggest that it plays a role in the glycolysis of the red cell. The slow rate of interconversion of estrone and estradiol-17/3, however, would appear to limit the importance of this system. It should be added that in the presence of plasma, the extent of the interconversion is smaller. This is due probably to the fact that a large fraction of the steroid is bound to plasma protein and therefore unavailable to red cells (31) (32) (33) (34) . Since a similar situation would be found in the general circulation of man, this would also reduce the importance of the system in vivo. 
